Related Experiment Video
Updated: Jul 8, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Kinases Controlling Stability of the Oncogenic MYCN Protein
Nailah Smith1, Eduard Reznik1, Brygida Bisikirska2
1Department of Biological Sciences, Columbia University, New York City, New York 10027, United States.
Abstract:
We previously identified the natural products isopomiferin and pomiferin as powerful, indirect MYCN-ablating agents. In this work, we expand on their mechanism of action and find that casein kinase 2 (CK2), phosphoinositide 3-kinase (PI3K), checkpoint kinase 1 (CHK1) and serine/threonine protein kinase 38-like (STK38L), as well as STK38, work synchronously to create a field effect that maintains MYCN stability. By systematically inhibiting these kinases, we degraded MYCN and induced cell death. Additionally, we synthesized and tested several simpler and more cost-effective pomiferin analogues, which successfully emulated the compound's MYCN ablating activity. Our work identified and characterized key kinases that can be targeted to interfere with the stability of the MYCN protein in NBL cells, demonstrating the efficacy of an indirect approach to targeting "undruggable" cancer drivers.
Insights
Natural products isopomiferin and pomiferin indirectly degrade MYCN by targeting key kinases like CK2 and PI3K. This approach offers a novel strategy for targeting MYCN in neuroblastoma cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- MYCN is a key oncogene in neuroblastoma (NBL) and is considered
- undruggable
- due to its lack of canonical binding sites.
Purpose of the Study:
- To elucidate the mechanism of action of isopomiferin and pomiferin in MYCN ablation.
- To identify key kinases involved in maintaining MYCN stability.
- To develop novel, cost-effective pomiferin analogues for MYCN targeting.
Main Methods:
- Systematic inhibition of identified kinases (CK2, PI3K, CHK1, STK38L, STK38).
- Synthesis and testing of pomiferin analogues.
- Assessment of MYCN degradation and NBL cell death induction.
Main Results:
- Identified a kinase network (CK2, PI3K, CHK1, STK38L, STK38) maintaining MYCN stability.
- Inhibition of these kinases led to MYCN degradation and NBL cell death.
- Synthesized pomiferin analogues retained MYCN ablating activity.
Conclusions:
- Established a novel indirect targeting strategy for MYCN in NBL cells.
- Demonstrated the therapeutic potential of targeting the identified kinase network.
- Pomiferin analogues represent promising, cost-effective therapeutic leads.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Destabilization of Microtubules
Abnormal Proliferation
Positive Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
Microtubule Instability

